Novynette (Desogestrel, Ethinylestradiol)

Novynette, a combined oral contraceptive, is indicated for hormonal contraception.

• Prevention of pregnancy: Provides reliable contraceptive protection when taken as directed.
• Menstrual cycle control: Helps achieve more predictable menstrual bleeding.
• Management of dysmenorrhea: May reduce menstrual pain associated with hormonal cycles.

• Desogestrel/Ethinylestradiol exerts its contraceptive effect by suppressing the mid‑cycle luteinising hormone surge, thereby preventing ovulation. The estrogen component stabilises the endometrial lining, while the progestogen thickens cervical mucus, creating a hostile environment for sperm penetration and implantation.

Novynette may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

• Nausea: Mild to moderate stomach upset.
• Breast tenderness: Sensitivity or swelling of breast tissue.
• Headache: Transient cranial discomfort.
• Spotting: Irregular light bleeding between periods.
• Weight gain: Slight increase in body weight.
• Mood changes: Fluctuations in emotional state.

Serious or Rare Side Effects

• Deep vein thrombosis: Formation of blood clots in deep veins.
• Pulmonary embolism: Blockage of pulmonary arteries by clots.
• Stroke: Interruption of blood flow to the brain.
• Myocardial infarction: Heart attack due to coronary blockage.
• Severe allergic reaction: Anaphylaxis or angioedema.
• Liver tumor: Rare hepatic neoplasm.

Novynette requires careful consideration of several safety aspects before use.

• Contraindicated in pregnancy: Category X, do not use during pregnancy.
• Smoking over age 35: Increased risk of cardiovascular events; avoid use.
• History of thromboembolic disorders: Assess risk before prescribing.
• Liver disease: Use with caution in hepatic impairment.
• Interactions with enzyme inducers: May reduce contraceptive efficacy.
• Store at ambient temperature: Keep in the original pack, protect from moisture and heat.

Novynette can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampicin): May markedly reduce hormone levels.
• Antiepileptic drugs (e.g., carbamazepine): Can lower contraceptive effectiveness.
• Protease inhibitors: May increase risk of adverse hormonal effects.

Moderate Interactions (Monitor Closely)

• Antifungals (e.g., ketoconazole): May raise estrogen concentrations.
• SSRIs (e.g., sertraline): Potentially increase bleeding tendency.
• St. John’s wort: May diminish contraceptive reliability.